Workflow
personalized healthcare offerings
icon
Search documents
JPMorgan maintains 2026 expense outlook; ROTCE target at 17%
Reuters· 2026-02-23 21:25
Group 1 - JPMorgan Chase maintains its forecast for annual adjusted expenses at $105 billion for 2026 [1] - The bank targets a return on tangible common equity (ROTCE) of 17% [1] - JPMorgan expresses confidence in achieving its longer-term ambitions in a presentation to investors [1] Group 2 - Return on tangible common equity is a key profitability metric for banks, indicating income generated from shareholder capital [2]
Hims & Hers forecasts 2026 revenue above estimates
Reuters· 2026-02-23 21:15
Core Viewpoint - Hims & Hers Health projects 2026 revenue to exceed estimates, driven by anticipated growth in sales of personalized healthcare products [1] Group 1: Revenue Forecast - The company forecasts revenue for 2026 to be above market estimates, indicating strong confidence in its growth trajectory [1] - Increased sales are expected from personalized healthcare offerings, which are becoming a significant part of the company's strategy [1] Group 2: Market Position - Hims & Hers Health is positioning itself to capitalize on the growing demand for personalized healthcare solutions, reflecting broader industry trends [1]